Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study
- PMID: 18187073
- PMCID: PMC2239343
- DOI: 10.1016/j.amjmed.2007.06.030
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study
Abstract
Purpose: The study purpose was to evaluate the ability of 6 biomarkers to improve the prediction of cardiovascular events among persons with established coronary artery disease.
Background: Cardiovascular risk algorithms are designed to predict the initial onset of coronary artery disease but are less effective in persons with preexisting coronary artery disease.
Methods: We examined the association of N-terminal prohormone brain natriuretic peptide (Nt-proBNP), cystatin C, albuminuria, C-reactive protein (CRP), interleukin-6, and fibrinogen with cardiovascular events in 979 Heart and Soul Study participants with coronary artery disease after adjusting for demographic, lifestyle, and behavior variables; cardiovascular risk factors; cardiovascular disease severity; medication use; and left ventricular ejection fraction. The outcome was a composite of stroke, myocardial infarction, and coronary heart disease death during an average of 3.5 years of follow-up.
Results: During follow-up, 142 participants (15%) developed cardiovascular events. The highest quartiles (vs lower 3 quartiles) of 5 biomarkers were individually associated with cardiovascular risk after multivariate analysis: Nt-proBNP hazard ratio (HR)=2.13 (95% confidence interval [CI], 1.43-3.18); cystatin C HR=1.72 (95% CI, 1.10-2.70); albuminuria HR=1.71 (95% CI, 1.15-2.54); CRP HR=2.00 (95% CI, 1.40-2.85); and interleukin-6 HR=1.76 (95% CI, 1.22-2.53). When all biomarkers were included in the multivariable analysis, only Nt-proBNP, albuminuria, and CRP remained significant predictors of events: HR=1.88 (95% CI, 1.23-2.85), HR=1.63 (95% CI, 1.09-2.43), and HR=1.82 (95% CI, 1.24-2.67), respectively. The area under the receiver operator curve for clinical predictors alone was 0.73 (95% CI, 0.68-0.78); adding Nt-proBNP, albuminuria, and CRP significantly increased the area under the receiver operator curve to 0.77 (95% CI, 0.73-0.82, P<.005).
Conclusion: Among persons with prevalent coronary artery disease, biomarkers reflecting hemodynamic stress, kidney damage, and inflammation added significant risk discrimination for cardiovascular events.
Figures


Similar articles
-
Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.Am J Hypertens. 2014 Mar;27(3):363-71. doi: 10.1093/ajh/hpt278. Epub 2014 Jan 27. Am J Hypertens. 2014. PMID: 24470529
-
N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.JAMA. 2005 Apr 6;293(13):1609-16. doi: 10.1001/jama.293.13.1609. JAMA. 2005. PMID: 15811980
-
N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.JAMA. 2007 Jan 10;297(2):169-76. doi: 10.1001/jama.297.2.169. JAMA. 2007. PMID: 17213400 Free PMC article.
-
N-terminal prohormone B-type natriuretic peptide and cardiovascular risk in stable coronary artery disease: a meta-analysis of nine prospective studies.Rev Cardiovasc Med. 2013;14(2-4):e92-8. doi: 10.3909/ricm0644. Rev Cardiovasc Med. 2013. PMID: 24448259 Review.
-
C-reactive protein and cardiovascular disease: weighing the evidence.Curr Atheroscler Rep. 2006 Sep;8(5):421-8. doi: 10.1007/s11883-006-0040-x. Curr Atheroscler Rep. 2006. PMID: 16901413 Review.
Cited by
-
Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.Clin Res Cardiol. 2016 May;105(5):421-31. doi: 10.1007/s00392-015-0937-x. Epub 2015 Nov 7. Clin Res Cardiol. 2016. PMID: 26547915
-
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.Circ Cardiovasc Qual Outcomes. 2017 Mar;10(3):e001493. doi: 10.1161/CIRCOUTCOMES.115.001493. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28280039 Free PMC article.
-
Factors contributing to hospitalization for gastroparesis exacerbations.Dig Dis Sci. 2009 Nov;54(11):2404-9. doi: 10.1007/s10620-009-0975-1. Dig Dis Sci. 2009. PMID: 19760157
-
Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography.Med Sci Monit. 2016 Aug 22;22:2956-61. doi: 10.12659/msm.897241. Med Sci Monit. 2016. PMID: 27548357 Free PMC article.
-
Analysis of the urinary peptidome associated with Helicobacter pylori infection.World J Gastroenterol. 2011 Feb 7;17(5):618-24. doi: 10.3748/wjg.v17.i5.618. World J Gastroenterol. 2011. PMID: 21350710 Free PMC article.
References
-
- Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002 Apr 16;105(15):1760–1763. - PubMed
-
- Vittinghoff E, Shlipak MG, Varosy PD, et al. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med. 2003 Jan 21;138(2):81–89. - PubMed
-
- Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999 Feb;59(1):1–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous